An FGFR4 polymorphism is implicated in the progression of neuroendocrine tumors

被引:0
|
作者
Serra, S. [1 ]
Zheng, L. [1 ]
Chetty, R. [1 ]
Ezzat, S. [1 ]
Asa, S. L. [1 ]
机构
[1] UHN, Dept Pathol, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:41 / 41
页数:1
相关论文
共 50 条
  • [41] FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression
    Zhao, Xiangdong
    Xu, Faliang
    Dominguez, Nestor P.
    Xiong, Yuanping
    Xiong, Zhongxun
    Peng, Hong
    Shay, Chloe
    Teng, Yong
    MOLECULAR CARCINOGENESIS, 2018, 57 (11) : 1616 - 1625
  • [42] FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
    Streit, S.
    Mestel, D. S.
    Schmidt, M.
    Ullrich, A.
    Berking, C.
    BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1879 - 1886
  • [43] Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma
    Charbonneau, Bridget
    Vogel, Rachel Isaksson
    Manivel, J. Carlos
    Rizzardi, Anthony
    Schmechel, Stephen C.
    Ognjanovic, Simona
    Subramanian, Subbaya
    Largaespada, David
    Weigel, Brenda
    HUMAN PATHOLOGY, 2013, 44 (09) : 1918 - 1926
  • [44] FGFR4 transmembrane domain polymorphism and cancer risk: A meta-analysis including 8555 subjects
    Xu, Wei
    Li, Yan
    Wang, Xueli
    Chen, Bo
    Wang, Yan
    Liu, Shifeng
    Xu, Jijun
    Zhao, Weihong
    Wu, Jianqing
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (18) : 3332 - 3338
  • [45] Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
    Kristen C Hart
    Scott C Robertson
    Martha Y Kanemitsu
    April N Meyer
    John A Tynan
    Daniel J Donoghue
    Oncogene, 2000, 19 : 3309 - 3320
  • [46] FGFR4 Polymorphism as Molecular Determinant of the Efficacy of mTOR Inhibitors In GH-Secreting Pituitary Adenomas
    Florio, Tullio
    ENDOCRINOLOGY, 2016, 157 (09) : 3400 - 3401
  • [47] Association between FGFR4 gene polymorphism and high-risk HPV infection cervical cancer
    Ya-Ping Li
    Lin Zhang
    Yu-Liang Zou
    Yan Yu
    Asian Pacific Journal of Tropical Medicine, 2017, (07) : 742 - 746
  • [48] FGFR4 GLY388ARG polymorphism modulates cancer patients' survival in pooled analysis
    Elisa Frullanti
    Tommaso A Dragani
    BMC Proceedings, 4 (Suppl 2)
  • [49] FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: A meta-analysis of 2618 cases and 2305 controls
    Xu, Bin
    Tong, Na
    Chen, Shu Q.
    Hua, Li X.
    Wang, Zeng J.
    Zhang, Zheng D.
    Chen, Ming
    BMC CANCER, 2011, 11
  • [50] Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
    Hart, KC
    Robertson, SC
    Kanemitsu, MY
    Meyer, AN
    Tynan, JA
    Donoghue, DJ
    ONCOGENE, 2000, 19 (29) : 3309 - 3320